Corvus Pharmaceuticals, Inc.

Q2 2025 13F Holders

Symbol
CRVS
CUSIP
221015100
Type
Equity
Class
COM
Num filers
96
Total reported value, excl. options
$167M
Manager Report Date Value ($000) Shares